ThermoGenesis Holdings THMO
$ 0.31
-25.84%
Quarterly report 2024-Q1
added 05-17-2024
Country |
USA |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Xiaochun Xu |
Employees in the company |
50 |
Shares |
551 K |
Market Cap[1] |
$ 171 K |
EBITDA (LTM) |
$ -3.38 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.